Lisata Therapeutics, Inc.
LSTA· Nasdaq
LSTALisata Therapeutics, Inc.
Released Aug 13, 2020, after the close
10-Q filed Aug 13, 2020, 44 days after period end · 0000320017-20-000085
| Metric | Q2 2019 | Q2 2018 | Q2 2017 | Q2 2016 |
|---|---|---|---|---|
| Net Income | $6.60M | -$5.14M | -$4.08M | $38.47M |
| EPS Diluted | $0.50 | -$0.49 | -$0.42 | $4.34 |
The same fiscal quarter, prior years. Thaler holds no estimates to compare against.
Lisata Therapeutics, Inc. · CIK 320017 · Engraved from SEC EDGAR
